Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis
Condition:   Pulmonary Langerhans Cell Histiocytosis Intervention:   Sponsors:   University of Cincinnati;   Rare Diseases Clinical Research Network;   National Heart, Lung, and Blood Institute (NHLBI) Recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2017 Category: Research Source Type: clinical trials